Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 1, no: 8 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q1W2
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 10 |
GO:0006629 | lipid metabolic process | 3 | 10 |
GO:0006631 | fatty acid metabolic process | 4 | 10 |
GO:0006635 | fatty acid beta-oxidation | 6 | 2 |
GO:0008152 | metabolic process | 1 | 10 |
GO:0009056 | catabolic process | 2 | 2 |
GO:0009062 | fatty acid catabolic process | 5 | 2 |
GO:0009987 | cellular process | 1 | 10 |
GO:0016042 | lipid catabolic process | 4 | 2 |
GO:0016054 | organic acid catabolic process | 4 | 2 |
GO:0019395 | fatty acid oxidation | 5 | 2 |
GO:0019752 | carboxylic acid metabolic process | 5 | 10 |
GO:0030258 | lipid modification | 4 | 2 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 10 |
GO:0034440 | lipid oxidation | 5 | 2 |
GO:0043436 | oxoacid metabolic process | 4 | 10 |
GO:0044237 | cellular metabolic process | 2 | 10 |
GO:0044238 | primary metabolic process | 2 | 10 |
GO:0044242 | cellular lipid catabolic process | 4 | 2 |
GO:0044248 | cellular catabolic process | 3 | 2 |
GO:0044255 | cellular lipid metabolic process | 3 | 10 |
GO:0044281 | small molecule metabolic process | 2 | 10 |
GO:0044282 | small molecule catabolic process | 3 | 2 |
GO:0046395 | carboxylic acid catabolic process | 5 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 10 |
GO:0072329 | monocarboxylic acid catabolic process | 6 | 2 |
GO:1901575 | organic substance catabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 10 |
GO:0003824 | catalytic activity | 1 | 10 |
GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity | 5 | 6 |
GO:0005488 | binding | 1 | 10 |
GO:0016491 | oxidoreductase activity | 2 | 10 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3 | 10 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4 | 10 |
GO:0036094 | small molecule binding | 2 | 10 |
GO:0043167 | ion binding | 2 | 10 |
GO:0043168 | anion binding | 3 | 10 |
GO:0051287 | NAD binding | 4 | 10 |
GO:0070403 | NAD+ binding | 4 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901265 | nucleoside phosphate binding | 3 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 144 | 146 | PF00675 | 0.436 |
CLV_NRD_NRD_1 | 300 | 302 | PF00675 | 0.483 |
CLV_NRD_NRD_1 | 49 | 51 | PF00675 | 0.333 |
CLV_PCSK_SKI1_1 | 111 | 115 | PF00082 | 0.379 |
CLV_Separin_Metazoa | 165 | 169 | PF03568 | 0.451 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.618 |
DOC_CYCLIN_RxL_1 | 108 | 118 | PF00134 | 0.451 |
DOC_CYCLIN_yCln2_LP_2 | 205 | 211 | PF00134 | 0.352 |
DOC_MAPK_gen_1 | 145 | 154 | PF00069 | 0.346 |
DOC_MAPK_gen_1 | 185 | 192 | PF00069 | 0.422 |
DOC_MAPK_RevD_3 | 96 | 111 | PF00069 | 0.451 |
DOC_PP2B_LxvP_1 | 205 | 208 | PF13499 | 0.352 |
DOC_PP4_FxxP_1 | 154 | 157 | PF00568 | 0.352 |
DOC_USP7_UBL2_3 | 119 | 123 | PF12436 | 0.354 |
DOC_USP7_UBL2_3 | 185 | 189 | PF12436 | 0.408 |
DOC_USP7_UBL2_3 | 284 | 288 | PF12436 | 0.352 |
DOC_USP7_UBL2_3 | 295 | 299 | PF12436 | 0.473 |
DOC_WW_Pin1_4 | 153 | 158 | PF00397 | 0.338 |
DOC_WW_Pin1_4 | 170 | 175 | PF00397 | 0.292 |
DOC_WW_Pin1_4 | 270 | 275 | PF00397 | 0.493 |
LIG_14-3-3_CanoR_1 | 219 | 225 | PF00244 | 0.408 |
LIG_14-3-3_CanoR_1 | 3 | 13 | PF00244 | 0.470 |
LIG_BRCT_BRCA1_1 | 123 | 127 | PF00533 | 0.451 |
LIG_BRCT_BRCA1_1 | 6 | 10 | PF00533 | 0.530 |
LIG_EH1_1 | 199 | 207 | PF00400 | 0.352 |
LIG_eIF4E_1 | 264 | 270 | PF01652 | 0.491 |
LIG_FHA_1 | 129 | 135 | PF00498 | 0.338 |
LIG_FHA_1 | 167 | 173 | PF00498 | 0.451 |
LIG_FHA_1 | 53 | 59 | PF00498 | 0.507 |
LIG_FHA_2 | 142 | 148 | PF00498 | 0.403 |
LIG_FHA_2 | 221 | 227 | PF00498 | 0.376 |
LIG_FHA_2 | 35 | 41 | PF00498 | 0.352 |
LIG_FHA_2 | 84 | 90 | PF00498 | 0.338 |
LIG_LIR_Gen_1 | 223 | 231 | PF02991 | 0.436 |
LIG_LIR_Nem_3 | 112 | 117 | PF02991 | 0.378 |
LIG_LIR_Nem_3 | 223 | 227 | PF02991 | 0.451 |
LIG_LIR_Nem_3 | 291 | 296 | PF02991 | 0.332 |
LIG_LIR_Nem_3 | 7 | 13 | PF02991 | 0.533 |
LIG_PCNA_yPIPBox_3 | 63 | 76 | PF02747 | 0.415 |
LIG_Pex14_1 | 260 | 264 | PF04695 | 0.451 |
LIG_RPA_C_Fungi | 40 | 52 | PF08784 | 0.412 |
LIG_SH3_3 | 235 | 241 | PF00018 | 0.352 |
LIG_SH3_3 | 262 | 268 | PF00018 | 0.352 |
LIG_SUMO_SIM_par_1 | 34 | 40 | PF11976 | 0.362 |
LIG_UBA3_1 | 113 | 119 | PF00899 | 0.432 |
LIG_UBA3_1 | 176 | 185 | PF00899 | 0.439 |
LIG_UBA3_1 | 57 | 63 | PF00899 | 0.493 |
LIG_WRC_WIRS_1 | 221 | 226 | PF05994 | 0.451 |
MOD_CK1_1 | 129 | 135 | PF00069 | 0.362 |
MOD_CK1_1 | 141 | 147 | PF00069 | 0.330 |
MOD_CK1_1 | 81 | 87 | PF00069 | 0.332 |
MOD_CK2_1 | 132 | 138 | PF00069 | 0.408 |
MOD_CK2_1 | 34 | 40 | PF00069 | 0.408 |
MOD_CK2_1 | 83 | 89 | PF00069 | 0.352 |
MOD_Cter_Amidation | 183 | 186 | PF01082 | 0.415 |
MOD_Cter_Amidation | 285 | 288 | PF01082 | 0.352 |
MOD_Cter_Amidation | 299 | 302 | PF01082 | 0.438 |
MOD_GlcNHglycan | 140 | 143 | PF01048 | 0.415 |
MOD_GlcNHglycan | 22 | 25 | PF01048 | 0.274 |
MOD_GlcNHglycan | 6 | 9 | PF01048 | 0.629 |
MOD_GSK3_1 | 122 | 129 | PF00069 | 0.366 |
MOD_GSK3_1 | 130 | 137 | PF00069 | 0.332 |
MOD_GSK3_1 | 166 | 173 | PF00069 | 0.358 |
MOD_N-GLC_1 | 129 | 134 | PF02516 | 0.352 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.575 |
MOD_NEK2_1 | 244 | 249 | PF00069 | 0.342 |
MOD_NEK2_1 | 46 | 51 | PF00069 | 0.352 |
MOD_NEK2_1 | 75 | 80 | PF00069 | 0.416 |
MOD_NEK2_1 | 9 | 14 | PF00069 | 0.443 |
MOD_NEK2_2 | 122 | 127 | PF00069 | 0.451 |
MOD_PIKK_1 | 39 | 45 | PF00454 | 0.353 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.539 |
MOD_Plk_1 | 129 | 135 | PF00069 | 0.352 |
MOD_Plk_1 | 53 | 59 | PF00069 | 0.352 |
MOD_Plk_4 | 122 | 128 | PF00069 | 0.449 |
MOD_Plk_4 | 34 | 40 | PF00069 | 0.352 |
MOD_Plk_4 | 53 | 59 | PF00069 | 0.238 |
MOD_Plk_4 | 75 | 81 | PF00069 | 0.438 |
MOD_ProDKin_1 | 153 | 159 | PF00069 | 0.338 |
MOD_ProDKin_1 | 170 | 176 | PF00069 | 0.292 |
MOD_ProDKin_1 | 270 | 276 | PF00069 | 0.493 |
MOD_SUMO_for_1 | 109 | 112 | PF00179 | 0.451 |
TRG_DiLeu_BaEn_1 | 212 | 217 | PF01217 | 0.376 |
TRG_DiLeu_BaLyEn_6 | 201 | 206 | PF01217 | 0.352 |
TRG_DiLeu_BaLyEn_6 | 271 | 276 | PF01217 | 0.493 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKX2 | Leptomonas seymouri | 78% | 100% |
A0A0S4JB86 | Bodo saltans | 61% | 100% |
A0A1X0P8Y1 | Trypanosomatidae | 62% | 100% |
A0A3Q8IQN1 | Leishmania donovani | 98% | 100% |
A4HNX4 | Leishmania braziliensis | 86% | 100% |
A4ICM0 | Leishmania infantum | 97% | 100% |
D7URM0 | Pseudomonas sp. | 29% | 95% |
E9ASN4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
P00348 | Sus scrofa | 55% | 97% |
P14755 | Oryctolagus cuniculus | 28% | 96% |
P34439 | Caenorhabditis elegans | 46% | 100% |
P41938 | Caenorhabditis elegans | 52% | 99% |
P45364 | Clostridioides difficile | 40% | 100% |
P45856 | Bacillus subtilis (strain 168) | 39% | 100% |
P52041 | Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787) | 38% | 100% |
P77851 | Thermoanaerobacterium thermosaccharolyticum (strain ATCC 7956 / DSM 571 / NCIMB 9385 / NCA 3814 / NCTC 13789 / WDCM 00135 / 2032) | 40% | 100% |
P83589 | Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422) | 28% | 88% |
P9WNP6 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 42% | 100% |
P9WNP7 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 42% | 100% |
Q0AVM2 | Syntrophomonas wolfei subsp. wolfei (strain DSM 2245B / Goettingen) | 41% | 100% |
Q16836 | Homo sapiens | 54% | 97% |
Q45223 | Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110) | 36% | 100% |
Q5RDZ2 | Pongo abelii | 27% | 96% |
Q61425 | Mus musculus | 56% | 97% |
Q811X6 | Rattus norvegicus | 27% | 96% |
Q88R32 | Pseudomonas putida (strain ATCC 47054 / DSM 6125 / CFBP 8728 / NCIMB 11950 / KT2440) | 29% | 95% |
Q8CQB9 | Staphylococcus epidermidis (strain ATCC 12228 / FDA PCI 1200) | 26% | 95% |
Q8CUW0 | Oceanobacillus iheyensis (strain DSM 14371 / CIP 107618 / JCM 11309 / KCTC 3954 / HTE831) | 28% | 99% |
Q8SPX7 | Bos taurus | 28% | 95% |
Q8SQ26 | Sus scrofa | 28% | 95% |
Q988C8 | Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) | 31% | 99% |
Q99KP3 | Mus musculus | 28% | 96% |
Q9RVG1 | Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422) | 40% | 100% |
Q9WVK7 | Rattus norvegicus | 56% | 97% |
Q9Y2S2 | Homo sapiens | 27% | 96% |
V5BPS0 | Trypanosoma cruzi | 65% | 95% |
W7MSH6 | Gibberella moniliformis (strain M3125 / FGSC 7600) | 26% | 95% |